Picture of Biovaxys Technology logo

BIOV Biovaxys Technology Cashflow Statement

0.000.00%
ca flag iconLast trade - 00:00
HealthcareSpeculativeMicro CapSucker Stock

Annual cashflow statement for Biovaxys Technology, fiscal year end - October 31st, CAD millions except per share, conversion factor applied.

2018
October 31st
2019
October 31st
2020
October 31st
2021
October 31st
Period Length:12 M12 M12 M12 M
Source:ARSARSARSARS
Standards:
IFRS
IFRS
IFRS
IFRS
Status:FinalFinalFinalFinal
Net Income/Starting Line-0.161-0.23-1.1-6.46
Non-Cash Items0.0100.3251.25
Discontinued Operations
Unusual Items
Other Non-Cash Items
Changes in Working Capital0.115-0.001-0.449-0.083
Change in Accounts Receivable
Change in Prepaid Expenses
Change in Accounts Payable
Cash from Operating Activities-0.036-0.231-1.23-5.29
Other Investing Cash Flow Items0.0610
Other Investing Cash Flow
Cash from Investing Activities0.0610
Financing Cash Flow Items0.052-0.0520-0.37
Other Financing Cash Flow
Net Issuance / Retirement of Stock
Cash from Financing Activities0.0520.4443.353.44
Foreign Exchange Effects
Beginning Cash Balance
Ending Cash Balance
Net Change in Cash0.0160.2132.19-1.83

Or unlock with your email

Or unlock with your email